| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.66B | 46.18B | 37.34B | 43.15B | 51.42B | 55.19B |
| Gross Profit | 12.21B | 12.13B | 10.61B | 10.95B | 15.49B | 15.71B |
| EBITDA | 3.34B | 2.99B | 2.20B | 2.63B | 7.18B | 8.71B |
| Net Income | 791.00M | 800.00M | 778.00M | 260.00M | 4.20B | 3.51B |
Balance Sheet | ||||||
| Total Assets | 71.13B | 73.55B | 76.03B | 71.39B | 72.60B | 80.59B |
| Cash, Cash Equivalents and Short-Term Investments | 23.13B | 26.67B | 23.10B | 26.73B | 27.90B | 33.28B |
| Total Debt | 19.34B | 21.24B | 20.43B | 18.29B | 13.55B | 15.88B |
| Total Liabilities | 38.44B | 39.96B | 41.39B | 37.50B | 38.06B | 47.67B |
| Stockholders Equity | 32.63B | 33.50B | 34.37B | 33.60B | 34.17B | 31.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.33B | -5.28B | -4.22B | -640.00M | 18.71B |
| Operating Cash Flow | 0.00 | 5.34B | -4.76B | -3.28B | 1.41B | 20.17B |
| Investing Cash Flow | 0.00 | -1.47B | -254.00M | -1.16B | -1.55B | -1.25B |
| Financing Cash Flow | 0.00 | -471.00M | 1.34B | 2.75B | -5.84B | 1.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.94T | 30.90 | 12.80% | 0.78% | 7.09% | 7.51% | |
79 Outperform | ¥108.63B | 15.13 | ― | 3.23% | 7.28% | 4.16% | |
78 Outperform | ¥320.90B | 8.42 | ― | 2.04% | -0.69% | -29.88% | |
76 Outperform | ¥46.41B | 4.58 | 6.12% | 2.67% | -7.95% | -34.83% | |
74 Outperform | ¥600.32B | 44.29 | 4.03% | 2.25% | 3.97% | -41.76% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥919.59B | 36.79 | 2.99% | 2.62% | 3.51% | ― |